The latest thought leadership from our expert teams

Active filters (1)
Opinion

Exploring the potential for non-contact monitoring for sepsis, the quick and costly killer

17th Jan 2020

Sepsis is a life-threatening response of the immune system to infection that can lead to tissue damage, organ failure and the risk of permanent disability or death. Detecting and treating it early can be highly effective in stopping progression. The trouble is that implementing the level of monitoring required to catch sepsis at the earliest stages is tough outside critical care settings. 

  • AI & Analytics
  • Connectivity & IoT
  • Digital health
  • Sensing
  • Signal processing
Whitepaper

The future of patient monitoring

1st Jul 2019

Patient monitoring is an inherent part of patient management. Intermittent and continuous measurements have a range of uses, from defining disease states and characterising progression to informing therapeutic approaches and...

  • AI & Analytics
  • Connectivity & IoT
  • Digital health
  • Digital security
  • Digital service innovation
  • Human factors
  • Product realisation
  • Sensing
  • User Experience (UX)
Opinion

The challenge of scale down models

10th May 2021

Scale-down models have become a popular development tool, especially in the bioprocessing industry. But how do you make them robust and reproducible?

  • Bioinnovation
Opinion

Our four iF DESIGN AWARDS put us in the top three nationally

5th May 2021

Winning a prestigious international design award for our product innovation here at Cambridge Consultants is obviously fantastic – so scooping not just one but four gongs in the coveted iF Design Awards is great for everyone involved. Andy Pigeon, our head of User centred Design reviews the four winners.

  • Human factors
  • Industrial design
  • User Experience (UX)
eBook

Creating Robust Bioprocessing scale-down models

4th May 2021

Scale-down models have become an increasingly common development tool, especially in the bioprocessing industry. Read our eBook to discover our approach to the challenge of scaling up scale down models.

  • Bioinnovation
Opinion

Surgical robotics: the earlier you manage risk the longer your runway for reward

26th Apr 2021

If you’re a surgical robotics start-up, the timing of your risk assessment will determine the level of success you achieve. Andrew Savarese, VP, Surgical Robotics & Advanced Surgical Systems, delves into his deep experience and comes up with crucial advice to make sure you spend the right money once, not the wrong money twice.

  • Digital health
  • Human factors
  • Physical sciences
  • Robotics
Opinion

CellPreserve: our innovation could help prolong the lives of cancer patients

7th Apr 2021

Diagnosing cancer early to treat it more effectively is vital. Here, Josh Gibson, senior physicist at Cambridge Consultants, unveils a potentially life-saving breakthrough in the field of liquid biopsy that’s been hailed by a leading innovation award jury…

  • Bioinnovation
  • Digital health
Opinion

Tri-Con 2021 reflects the rapid pace of development in diagnostics

8th Mar 2021

The past year has seen an unprecedented acceleration of innovation in the diagnostics space. Reflecting on the virtual themes and debates at Molecular Med Tri-Con 2021, Head of Life Sciences Symon Cotton says that the speed of tests and vaccines coming to market is not having an adverse effect on quality. Medical developments can be safely delivered to quicker timescales...

  • Bioinnovation
  • Digital health
  • Human factors
Opinion

What’s next for targeted medicine? We report back from SLAS 2021

4th Feb 2021

Symon Cotton, Head of Life Sciences at Cambridge Consultants, attended this year’s Society for Laboratory Automation and Screening conference, SLAS2021. Even in virtual form, the speakers dazzled with fresh and exciting ideas for the future of patient treatments.

  • Bioinnovation
  • Digital health
Opinion

System architecture – your vital blueprint for success as a surgical start-up

4th Feb 2021

Now you’ve got a talented team together, surely it’s time to push on to design and build your device? Not quite. In the latest in his series of articles, our VP Surgical Robotics & Advanced Surgical Systems Andrew Savarese explains the crucial importance of system architecture, the vital blueprint for project efficiency… 

  • Digital health
  • Human factors
  • Physical sciences
  • Robotics
Opinion

Our core technology is at the heart of the world’s first FDA-approved fully at-home COVID-19 test

22nd Jan 2021

The rapid, at home COVID-19 antigen test from digital diagnostics company Ellume features core technology from Cambridge Consultants. Read how this FDA approved test is set to be a game-changer in the global pandemic.

  • Bioinnovation
  • Digital health
  • Fluids & thermodynamics
  • Sensing
Opinion

UK Human Tissue Authority licence enhances our next-generation therapy development

17th Dec 2020

We are delighted to report a significant step forward as we grow our bioinnovation capability as we have received our licence from the UK Human Tissue Authority to store human tissue for research purposes. This opens the way to future development in cell therapies and regenerative medicine. 

  • Bioinnovation